Maria Angela Losi is an expert in Cardiology at Federico II University Hospital (Italy). As of July 2026, ScienceLeadR ranks Maria Angela Losi in the top 1% of experts worldwide for Cardiomyopathies. Maria Angela Losi has authored 183 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 536 (community average: 125). How the SLR is computed.

LeadR Profile

Maria Angela Losi Federico II University Hospital Italy
536 ScienceLeadR Reputation 536
Network Map

Cardiology

Subspecialties: Internal Medicine - Hematology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026

Source: PubMed

University of Naples Federico II

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 183

Citations

Citations: 5 901 1st author: 32 Last author: 29 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Beta-blockers in patients with uncomplicated arterial hypertension: data from the Campania Salute Network Registry.
PMID 42184976 — registries, hypertension, treatment adherence and compliance, heart failure, heart, cardiovascular diseases, therapeutics
Eur Heart J Qual Care Clin Outcomes20260
Effect of Mavacamten Therapy on Myocardial Systolic Function Assessed by 3D Echocardiography.
PMID 41778934 — echocardiography, therapeutics, echocardiography, three-dimensional, cardiomyopathies
JACC Case Rep20260
Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy.
PMID 41711742 — exercise, research design, heart failure, exercise test, heart, cardiomyopathy, hypertrophic, cardiomyopathies
ESC Heart Fail20260
Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
PMID 41519390 — cardiology, cardiomyopathy, hypertrophic, therapeutics, cardiomyopathies
Int J Cardiol20260
Arrhythmic risk in mitral valve prolapse with mitral annular disjunction: meta-analysis of longitudinal studies.
PMID 41402368 — longitudinal studies, mitral valve, odds ratio, natural science disciplines, mitral valve prolapse, prolapse
Sci Rep20250

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map